|Articles|November 2, 2012
- Pharmaceutical Technology-11-02-2012
- Volume 36
- Issue 11
Pharmaceutical Technology, November 2012 Issue (PDF)
Early-Stage Drug Development
Advertisement
Articles in this issue
almost 14 years ago
Weighing Access and Affordabilityalmost 14 years ago
ISPE Annual Meeting Seeks to Foster Global Changealmost 14 years ago
Product Analysis Key to Biosimilar Developmentalmost 14 years ago
Partnering in Antibody Drug Conjugatesalmost 14 years ago
In the Spotlight November 2012almost 14 years ago
Q&A with Yves de Montcheuil of Talendalmost 14 years ago
A Troubleshooting Guide for Topical Drug Manufacturingalmost 14 years ago
Frozen Assetsalmost 14 years ago
Creating a Holistic Procurement Systemalmost 14 years ago
EU Sets Guidelines for Biosimilar Monoclonal AntibodiesAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem
2
Three Formats, One Platform: Halo's New Sterile Fill-Finish Line
3
BMS Bets on Flexible Capacity With $2.3B Texas Campus
4
Danish Biotechs Attracting Investor Attention
5
